Sinopharm Group Co. Ltd. Share Price and Company Fundamentals
Last traded: Today at 8:08 AM
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices Distribution segment distributes medical devices, as well as provides installation and maintenance services. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the distribution of laboratory supplies; manufacture and distribution of chemical reagents; and production and sale of pharmaceutical products. The company rents and manages properties; distributes medical instruments and equipment, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. It also manages medical project investment, consulting, and technology training activities; and manufactures medicines. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Key Metrics
PE ratio
8.83
PB ratio
0.73
Dividend yield
3.39%
Beta
0.63
Market cap
$68.03B
Enterprise value
$162.45B
Company profile
| Industry / Sector | Medical Distribution / Healthcare |
|---|---|
| Full time employees | 108217 |
| Website | https://www.sinopharmgroup.com.cn |
| Mailing address | Sinopharm Group Building No. 385, East Longhua Road Huangpu District Shanghai 200023 China |
| Phone / Fax | 86 21 2305 2666 / 86 21 2305 2888 |
Dividends
Dividend yield
3.39%
Dividend amount
$0.74
Payout ratio
30.98%
5Y Avg. yield
-%
Sinopharm Group Co. Ltd. paid $0.74 dividend and the ex-dividend date was 16 Jun 2025.The dividend payout ratio is 30.98%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.1099 dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Sinopharm Group Co. Ltd..
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Wanyong Lian | President & Executive Director | 54 | |
| Ms. Xiaojuan Li | Chief Financial Officer | 49 | |
| Mr. Binghua Yang | Executive Director | 45 | |
| Mr. Yijian Wu | VP, Secretary to the Board & Company Secretary | 55 |
Profitability and management effectiveness
Profit margin
1.23%
Operating margin
2.84%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Sinopharm Group Co. Ltd. is 68.03B and its enterprise value is 162.45B. The enterprise value to revenue ratio of 1099 is 0.28. The enterprise value to EBITDA ratio of 1099 is 8.28.
The 1099's stocks Beta value is 0.63 making it 37% less volatile compared to HKEX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Sinopharm Group Co. Ltd. (HKEX:1099) Frequently Asked Questions
1. What is Sinopharm Group Co. Ltd.'s Stock Symbol?
Sinopharm Group Co. Ltd. trades on HKEX under the ticker symbol "1099".
2. What is Sinopharm Group Co. Ltd.'s stock price today?
One share of 1099 stock can currently be purchased for approximately $21.8.
3. How can I contact Sinopharm Group Co. Ltd.?
Sinopharm Group Co. Ltd.'s mailing address is Sinopharm Group Building No. 385, East Longhua Road Huangpu District Shanghai 200023 China. The company can be reached via phone at 86 21 2305 2666.
4. What is Sinopharm Group Co. Ltd.'s official website?
The official website of Sinopharm Group Co. Ltd. is https://www.sinopharmgroup.com.cn.